More than 185 million patients now have access to HeartFlow FFRct

451
HeartFlow FFRCT

HeartFlow has revealed that seven new commercial payers issued positive medical policies covering the use of the HeartFlow FFRct analysis following a coronary computed tomography angiogram. A press release reports that the HeartFlow analysis is a non-invasive technology that creates a personalised 3D model of the heart and simulates blood flow to help clinicians diagnose and treat patients with suspected heart disease.

The positive medical policies were issued by Cigna; Florida Blue; the Blue Cross and Blue Shield plans of Michigan, North Carolina, and Vermont; Highmark, Inc.; and Independence Blue Cross. Commercial coverage for the HeartFlow analysis is now available for approximately 130 million patients, in addition to the Centers for Medicare & Medicaid Services (CMS) recent decision to assign a New Technology APC payment for the HeartFlow FFRct Analysis for more than 55 million Medicare beneficiaries.

John H Stevens, president and chief executive officer of HeartFlow, comments: “These positive coverage decisions reinforce the clinical and economic value of the HeartFlow analysis in addressing how heart disease is diagnosed and treated. With the growing momentum of coverage, a wealth of scientific evidence, and unparalleled technology, the HeartFlow analysis is poised to become the standard of care for patients with suspected heart disease.”

(Visited 112 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here